gefenbiomed | investments

G&G BIOTECHNOLOGY

THE WORLD'S FIRST LIGHTWEIGHT

BREAST IMPLANT RANGE

QUIET THERAPEUTICS LTD

PROPRIETARY UNIQUELY TARGETED DELIVERY

SYSTEM FOR CHEMOTHERAPE PEPTIDES AND RNAI

NOVAREMED

INNOVATIVE SOLUTION FOR THOSE

WHO SUFFER FROM CHRONIC NEUROPATH

CLEAR-CUT

MOBILE MRI SYSTEM THAT ENABLES BRINGING

THE POWER OF MRI TO CANCER SURGERY

ABOUT GEFEN BIOMED INVESTMENT

GEFEN Biomed Investments main activity is to locate, screen and invest in early-stage companies and promising initiatives, leveraging Israeli chief scientist, strategic partners or individual capitals side by side to its own funds. GEFEN expertise in the life-science area,

Gefenbiomed News

MinInvasive Completes an Investment Agreement for USD 3.9M

17/06/2014

Magal, Israel, June 17th, 2014 – MinInvasive Ltd., which develops an arthroscopic device for shoulder rotator cuff repair surgeries, has secured USD 3.9M through an investment agreement with a group of new and existing investors… Read more

Israeli Chief Scientist Approves Inclusion and Funding of SOLIGHT Ltd. Within the A.T.I Business Incubator

18/06/2014

Haifa, Israel, June 18th, 2014 – SOLIGHT ltd., a company developing solar lighting systems for buildings utilizing an optimal stationary receptor, has been approved by the Israeli Chief Scientist to be included as a part of the A.T.I business incubator, within the Horizon Green Tech Ventures Project. The inclusion involves NIS 2M in funding from the Chief Scientist’s grant… Read more

Clear-Cut Medical announces CE Marking of its ClearSight™ MRI system for the examination of breast tissue

23/09/2014

The ClearSight™ system is a revolutionary compact Magnetic Resonance Imaging system intended for the assessment of the margins of excised breast lumps taken from breast cancer patients undergoing Breast Conserving Surgery or Lumpectomy procedures. The CE Marking of the ClearSight™ system allows the commercialization of the system in Europe.… Read more